Grey Market Premium (GMP) in IPOs: What It Is, How It Works, and Risks

What is the IPO grey market?

The IPO grey market is an unregulated, off-exchange market in which participants informally trade IPO-related instruments before the official listing date. The activity occurs outside the regulatory framework of SEBI, NSE, BSE and the RBI. There is no exchange platform, no central counterparty, no clearing corporation, no margin system, and no legal recourse in case of default.

What gets traded in the grey market falls into three buckets:

• Application rights — the right to whatever allotment a particular IPO application eventually receives, transferred by the original applicant to a secondary buyer. This is the kostak market.
• Conditional allotment expectations — the expected delivery of allotted shares contingent on the applicant actually receiving an allotment. This is the subject-to market.
• Post-allotment shares — already allotted but not yet listed shares, traded between holders and buyers ahead of the listing date. The premium quoted here is the headline GMP figure.

All three forms operate purely on personal trust between the buyer, seller, and an intermediating dealer. Settlement is in cash. There is no documentation that would be enforceable in court.

How the grey market operates

The grey market is a distributed network of OTC dealers spread across India's major commercial centres. Historically, the most active hubs have been Surat, Mumbai, Delhi, Ahmedabad, Rajkot and Indore — cities with deep mercantile communities and long histories of informal financial trading.

A typical chain works as follows. A handful of large dealers in each city act as market makers — they continuously quote two-way prices for active IPOs. Smaller sub-dealers and brokers sit between these market makers and end participants (HNI investors, arbitrageurs, retail speculators). When a retail applicant wants to lock in a guaranteed return on their IPO application, they approach a sub-dealer who quotes a kostak or subject-to rate. When a buyer wants exposure to the upcoming listing without applying themselves, they pay that quoted rate to the sub-dealer who passes it through the chain to the original applicant.

Settlement happens after the listing date. The original applicant delivers the shares to the dealer, the dealer pays the negotiated amount in cash, and the chain settles down to the end buyer who ultimately receives the shares. Disputes — for example, when one party defaults on a settlement — are typically resolved through informal community pressure rather than legal action, since these contracts are not enforceable.

GMP: Grey Market Premium

GMP is the per-share premium quoted in the grey market for an IPO before its listing date. It is an absolute rupee figure, not a percentage. For an IPO with a price band cap of ₹350, a GMP of ₹120 implies that grey market participants expect (or are willing to pay for) the stock to list around ₹470 — that is, ₹350 issue price plus ₹120 premium.

The expected listing price as observed via GMP is therefore calculated as:

Expected listing price = Issue price (cap) + GMP

GMP can also be negative, in which case the grey market is quoting a discount to the issue price. Negative GMP is rare but has historically appeared when subscription numbers are weak, broad market sentiment is poor, or specific concerns emerge about the issuer late in the bidding window.

Kostak rate

The kostak rate is a flat fee paid to the original IPO applicant in exchange for the right to whatever allotment that application receives — including no allotment at all. It is a fixed payment made at the time the application form is sold, and it does not depend on whether any shares are subsequently allotted.

For example, a buyer might pay ₹600 to a retail applicant for the right to their full ₹15,000 application. If the applicant receives one lot worth a listing-day market value of ₹18,000, the buyer effectively bought ₹3,000 of upside for ₹600. If the applicant receives nothing, the buyer simply loses the ₹600 paid — that is the cost of the option-like exposure.

Kostak is an option-style trade — the buyer pays a premium for uncertain payoff. It is most attractive when subscription probabilities are moderate, expected listing premiums are high, and the kostak rate is low relative to expected gains.

Subject-to rate

The subject-to rate is a premium paid only if the IPO applicant actually receives an allotment. If no allotment, no payment is exchanged. The buyer pays the subject-to rate per allotted lot — typically a substantially higher figure than the kostak rate, because the contingent nature shifts more risk onto the buyer.

For example, a subject-to rate of ₹4,500 means the buyer pays ₹4,500 to the original applicant if the application receives one lot allotment. The buyer's payoff is the listing-day market value of the allotted lot minus the issue cost minus the subject-to fee. If no allotment, both parties walk away with no obligation.

The relationship between kostak, subject-to and allotment probability roughly satisfies:

Kostak rate ≈ Subject-to rate × Allotment probability

So if kostak is ₹600 and subject-to is ₹4,500, the implied allotment probability is roughly 13%. This is one way grey market professionals back out their working estimate of allotment odds.

Distinguishing GMP, kostak and subject-to

The three rates measure different things and should not be confused:

• GMP: Per-share premium on already-allotted IPO shares awaiting listing. Quoted in rupees per share.
• Kostak: Flat fee for the entire application with no allotment guarantee. Quoted in rupees per application.
• Subject-to: Premium paid per allotted lot, only if allotment happens. Quoted in rupees per lot.

A given IPO will simultaneously have all three rates being quoted, and they reflect different views — the GMP reflects expected listing pop, the subject-to reflects allotment-conditional listing pop, and the kostak reflects the unconditional value of the application including allotment uncertainty.

How GMP is calculated and reported

Dealers in the grey market continuously update their two-way quotes based on subscription numbers, broad market mood, anchor investor quality, peer comparisons, and conversations with institutional contacts. As subscription momentum builds, GMP tends to rise. As subscription disappoints, GMP often falls.

Multiple unofficial websites and Telegram channels aggregate dealer quotes into headline GMP figures. The aggregation methods are not transparent — different sources publish different figures for the same IPO at the same time. The figures often update multiple times a day during the bidding window.

There is no central authority verifying the quotes. There is no audit trail. There is no requirement that the published figure reflects an actual transaction. In practice, the published GMP is a rough consensus of dealer chatter, useful for sentiment tracking but not for treating as a market price in the regulated sense.

Historical GMP examples (illustrative only)

Educational discussions of GMP often reference historical examples to illustrate how loosely GMP correlated with actual listing outcomes. The following are illustrative observations drawn from publicly reported financial commentary, in past tense:

• Several mainboard IPOs over the past decade carried GMP figures of ₹100-200 per share immediately before listing, and listed broadly in line with the implied premium.
• Other high-profile IPOs with elevated GMP saw listing prices fall well short of the implied figure, with the GMP collapsing in the days immediately preceding the listing as broader market conditions weakened.
• Conversely, some IPOs with very modest or near-zero GMP historically delivered strong listing-day premiums when retail subscription momentum surprised on the upside late in the bidding window.
• In bearish phases of the market — for example during sharp corrections or global shocks — even IPOs with strong GMP initially have at times listed flat or below issue price.

The pattern that emerges from these illustrations is that GMP is best understood as a real-time sentiment indicator that trades off against actual listing-day market conditions, not as a deterministic predictor of listing price.

Why retail investors track GMP

Retail interest in GMP is driven by a few practical motivations:

• Subscription decision: A high GMP is often interpreted as a signal of strong demand and probable listing-day gains. Many retail investors decide whether to apply based partly on the GMP figure.
• Listing-day exit planning: If allotted, knowing the prevailing GMP helps anchor expectations for what listing price might emerge — useful for mentally preparing the exit decision.
• Comparing IPOs: When multiple IPOs are open simultaneously, retail investors sometimes use GMP as a shorthand for comparing perceived demand intensity.

These motivations are understandable, but they should be balanced against the structural unreliability of GMP itself.

Risks of grey market dealings

For investors who are tempted to participate directly in the grey market — buying or selling kostak, subject-to or pre-listing shares — the risks are substantial:

• No SEBI regulation: The grey market is entirely outside the SEBI framework. Disputes have no formal recourse.
• Counterparty default risk: If the dealer or counterparty defaults — refuses to deliver shares, refuses to pay, disappears — there is no clearing corporation guarantee. Recovery depends on community pressure or personal connections.
• Settlement disputes: Disputes over the exact amount, the listing-day reference price, or the timing of settlement frequently arise. Without enforceable contracts, these disputes can drag on or simply lapse with one side losing entirely.
• Cash-only settlement: Most grey market transactions settle in cash, raising tax compliance concerns and falling outside the formal financial system.
• Information asymmetry: Dealers see the full order book and have far better information than retail participants. Retail investors who participate are usually taking the worse end of the spread.
• Quoted figures may not reflect transactable prices: Even the published GMP often does not represent prices at which retail-size trades can actually be executed. Real fills can be substantially worse than the headline number suggests.

GMP as sentiment indicator vs absolute predictor

The most balanced way to think about GMP is as one input among many for sentiment tracking — not as a deterministic prediction of the listing price. A high and rising GMP suggests broad-based retail enthusiasm. A collapsing GMP just before listing is a cautionary signal. A persistently low GMP throughout the bidding window suggests muted demand.

But none of these signals translate cleanly into listing-day prices, which depend on the actual flow of buy and sell orders in the special pre-open session, the broader market mood that morning, and the size of the floating allotment. Anchor investors, mutual funds and FPIs who participated in the QIB portion are the dominant determinants of price action on listing day, not the unregulated grey market.

Important caveat

The grey market is unregulated, opaque and risky. Direct participation in grey market trades carries counterparty default risk with no legal recourse. This article describes how the grey market works for educational completeness — it is not a guide encouraging participation. For investors operating within the regulated ecosystem, the relevant question is how to interpret published GMP figures as one sentiment data point, while recognising their structural limitations.

Build the foundation

GMP is best understood within the broader IPO framework. For the full mechanics, see our dedicated guide on how IPOs work in India. For details on how shares get allocated to retail applicants, see the IPO allotment process. And for a foundational primer on IPOs in general, see our IPO guide for India.